BlackRock Japan’s Clovis Oncology, Inc. CLVS Stock Holding History

BlackRock Japan’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$10K	Buy	236 +24	+11%	+$845	﹤0.01%	1225
2016 Q3	$8K	Buy	+212	New	+$4.55K	﹤0.01%	1228
2016 Q2	–	Sell	-547	Closed	-$11K	–	1512
2016 Q1	$11K	Hold	547	–	–	﹤0.01%	1281
2015 Q4	$19K	Buy	547 +204	+59%	+$13.2K	﹤0.01%	1171
2015 Q3	$32K	Buy	343 +33	+11%	+$2.86K	﹤0.01%	1043
2015 Q2	$27K	Buy	310 +149	+93%	+$12.8K	﹤0.01%	1154
2015 Q1	$12K	Buy	+161	New	+$11.4K	﹤0.01%	1228
2014 Q2	–	Sell	-413	Closed	-$29K	–	1429
2014 Q1	$29K	Buy	+413	New	+$30.3K	﹤0.01%	1235

Other funds holding CLVS

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock Japan's CLVS Position: Q4 2016 in Review

BlackRock Japan increased its Clovis Oncology, Inc. (CLVS) stake by 11% in Q4 2016, buying an estimated $845 and bringing the position to 236 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #1225.

BlackRock Japan first reported a position in CLVS in Q1 2014 and has held it in 8 quarters since. The position peaked at $32K in Q3 2015. 167 funds tracked by Wall St. Rank hold CLVS as of Q4 2016.

BlackRock Japan held 236 shares of Clovis Oncology, Inc. worth $10K as of Q4 2016.
BlackRock Japan bought 24 Clovis Oncology, Inc. shares in Q4 2016, an estimated $845.
Clovis Oncology, Inc. made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1225 holding.
BlackRock Japan first reported a position in Clovis Oncology, Inc. in Q1 2014 and has held it in 8 quarters since.
BlackRock Japan's Clovis Oncology, Inc. position peaked at $32K in Q3 2015.
167 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.